Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1364-1368

  Liu, Qian ^a,b,c   Li, Jia ^a,b,c   Pu, Gaobin ^a,b,c   Zhang, Fang ^a,b,c   Liu, Hongyan ^a,b,c   Zhang, Yongqing ^a,b,c  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shandong Fine Breeding Engineering Research Center of Chinese Medicinal Materials   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Breast cancer; co delivery; hyaluronic acid; nanostructured lipid carriers; surface decorated

Indexed keywords

BAICALEIN; DOXORUBICIN; HERMES ANTIGEN; HYALURONIC ACID; LIPID; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; UNCLASSIFIED DRUG; DRUG CARRIER; FLAVANONE DERIVATIVE; NANOMATERIAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER RESISTANCE; CANCER SIZE; CELL ADHESION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MCF 7 CELL LINE; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE CHARGE; ZETA POTENTIAL; ANIMAL; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; MCF-7 CELL LINE; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLAVANONES; HUMANS; HYALURONIC ACID; LIPIDS; MCF-7 CELLS; MICE; NANOSTRUCTURES;

EID: 84975317712     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1031295     Document Type: Article

References (35)

1. P.Armutlu, M.E.Ozdemir, F.Uney-Yuksektepe,. (2008). Classification of drug molecules considering their IC50 values using mixed-integer linear programming based hyper-boxes method. BMC Bioinformatics 9:411
2. K.Deepa, S.Singha, T.Panda. (2014). Doxorubicin nanoconjugates. J Nanosci Nanotechnol 14:892–904
3. W.H.De Jong, P.J.Borm. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133–49
4. D.Dong, W.Gao, Y.Liu,. (2015). Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer. Cancer Lett 359:178–86
5. E.Esposito, L.Ravani, M.Drechsler,. (2015). Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study. Mater Sci Eng C Mater Biol Appl 48:328–36
6. X.Fan, J.Chen, Q.Shen. (2013). Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. Int J Pharm 458:296–304
7. Y.K.Fong, C.R.Li, S.K.Wo,. (2012). In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein. J Ethnopharmacol 141:742–53
8. F.Greco, M.J.Vicent. (2009). Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 61:1203–13
9. Y.Guo, L.Wang, P.Lv,. (2015). Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer. Oncol Lett 9:1065–72
10. O.Harush-Frenkel, E.Rozentur, S.Benita,. (2008). Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9:435–43
11. C.W.How, A.Rasedee, S.Manickam,. (2013). Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity. Colloids Surf B Biointerfaces 112:393–9
12. H.Z.Lee, H.W.Leung, M.Y.Lai,. (2005). Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 25:959–64
13. T.Lee, E.K.Lim, J.Lee,. (2013). Efficient CD44-targeted magnetic resonance imaging (MRI) of breast cancer cells using hyaluronic acid (HA)-modified MnFe2O4 nanocrystals. Nanoscale Res Lett 8:149
14. L.Liu, Y.Tang, C.Gao,. (2014a). Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf B Biointerfaces 115:125–31
15. Y.Liu, L.Wang, Y.Zhao,. (2014b). Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Int J Pharm 476:169–77
16. T.Y.Liu, W.Gong, Z.J.Tan,. (2015). Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX. PLoS One 10:e0114851
17. J.Pardeike, A.Hommoss, R.H.Müller. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366:170–84
18. Y.Peng, C.Guo, Y.Yang,. (2015). Baicalein induces apoptosis of human cervical cancer HeLa cells in vitro. Mol Med Rep 11:2129–34
19. V.M.Platt, F.C.SzokaJr. (2008). Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm 5:474–86
20. H.S.Rahman, A.Rasedee, C.W.How,. (2013). Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomed 8:2769–81
21. M.Saraswathy, S.Gong. (2013). Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31:1397–407
22. M.J.Seo, H.S.Choi, H.J.Jeon,. (2014). Baicalein inhibits lipid accumulation by regulating early adipogenesis and m-TOR signaling. Food Chem Toxicol 67:57–64
23. M.Sun, S.Nie, X.Pan,. (2014). Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro. Colloids Surf B Biointerfaces 113:15–24
24. O.Taratula, A.Kuzmov, M.Shah,. (2013). Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release 171:349–57
25. D.M.Tichota, A.C.Silva, J.M.Sousa Lobo,. (2014). Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration. Int J Nanomed 9:3855–64
26. A.Trapani, D.Mandracchia, C.Di Franco,. (2015). In vitro characterization of 6-Coumarin loaded solid lipid nanoparticles and their uptake by immunocompetent fish cells. Colloids Surf B Biointerfaces 127C:79–88
27. M.J.Tsai, P.C.Wu, Y.B.Huang,. (2012). Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 423:461–70
28. N.Wang, D.Ren, S.Deng,. (2014). Differential effects of baicalein and its sulfated derivatives in inhibiting proliferation of human breast cancer MCF-7 cells. Chem Biol Interact 221:99–108
29. X.Yan, X.Rui, K.Zhang. (2015). Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol Rep 33:737–43
30. X.Yang, A.K.Lyer, A.Singh,. (2015). MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer. Sci Rep 5:8509
31. L.Yuan, C.Liu, Y.Chen,. (2013). Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model. Int J Nanomed 8:4339–50
32. J.L.Zaro. (2015). Lipid-based drug carriers for prodrugs to enhance drug delivery. AAPS J 17:83–92
33. X.Zhao, Q.Chen, W.Liu,. (2014). Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. Int J Nanomed 10:257–70
34. T.C.Zhang, J.N.Chen, Y.Zhang,. (2011). Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur J Pharm Sci 43:174–9
35. H.Zhang, J.Li, W.Sun,. (2014). Hyaluronic acid-modified magnetic iron oxide nanoparticles for MR imaging of surgically induced endometriosis model in rats. PLoS One 9:e94718